Bring patient, doctor and field signals together to decide whom to reach, what to do next and what actually worked.
Each solution answers one question a brand team asks. Brands combine the ones they need.
What real programmes combined, and what they achieved.
| Programme | Find the patients | Target the doctors | Engage each doctor | Plan resources | Prove the impact | Deliver to the field | Result |
|---|---|---|---|---|---|---|---|
| OncologyBreast cancer franchise, US | not used | not used | 5×field uplift | ||||
| ImmunologyLupus launch | not used | not used | not used | not used | not used | 8-figureincremental revenue | |
| RespiratoryAsthma brand | not used | not used | not used | not used | not used | +30%prescriptions | |
| RespiratoryCOPD launch | not used | not used | not used | not used | not used | +17%targeting precision | |
| Respiratory, CVRMGermany, Poland, Japan | not used | not used | not used | not used | +3.0%monthly sales lift |
Claims captured the biomarker status of only 1–2% of patients, so the market looked small and reps called on familiar names.
Enrichment rebuilt the eligible population, targeting ranked the doctors treating them, next best indication and action told reps what to do, and one app put it in their hands.
Measured against a 1:1 matched cohort with an independent data partner.
incremental revenue from targeting alone at a lupus launch, with a 292% NPS lift on contacted doctors.
causal monthly sales lift from next best content in Germany, against matched territories.
precision finding COPD early adopters before they prescribe.
